Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
- PMID: 29713141
- PMCID: PMC5907885
- DOI: 10.2147/OPTH.S158873
Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
Erratum in
-
Erratum: Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy [Corrigendum].Clin Ophthalmol. 2018 Sep 4;12:1673. doi: 10.2147/OPTH.S185201. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30233130 Free PMC article.
Abstract
Purpose: We retrospectively reviewed patients with postoperative neovascular glaucoma (NVG) after vitrectomy for proliferative diabetic retinopathy to investigate how variables assessed before, during, and after vitrectomy are associated with the requirement for filtration surgery.
Patients and methods: The subjects in this retrospective, observational, comparative study were 55 consecutive patients (61 eyes) who underwent vitrectomy for proliferative diabetic retinopathy at Toho University Sakura Medical Center between December 2011 and November 2016, were followed up for at least 6 months after surgery, and developed NVG within 2 years after surgery. They comprised 44 men and 11 women of mean age 52.4±9.1 years, who were followed up for a mean 7.1±6.1 months. We collected data on the following 16 variables: sex, age, history of panretinal photocoagulation completed within 3 months before vitrectomy, presence/absence of a lens, obvious iris/angle neovascularization, tractional retinal detachment, diabetic macular edema, vitreous hemorrhage, visual acuity and intraocular pressure before vitrectomy and at the onset of NVG, glycated hemoglobin, fasting blood glucose, estimated glomerular filtration rate, and use of intraoperative gas tamponade.
Results: Logistic regression analysis with the backward elimination method identified preoperative fasting hyperglycemia (P=0.08), high intraocular pressure at the onset of NVG (P=0.04), and use of gas tamponade during vitrectomy (P=0.008) to be significant risk factors for requirement of filtration surgery.
Conclusion: Preoperative fasting hyperglycemia, high intraocular pressure at the onset of NVG, and use of gas tamponade during vitrectomy predispose patients to require filtration surgery in the event of postoperative NVG.
Keywords: gas tamponade; neovascular glaucoma; proliferative diabetic retinopathy; vitrectomy.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.Clin Ophthalmol. 2018 Nov 14;12:2323-2329. doi: 10.2147/OPTH.S184959. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30532517 Free PMC article.
-
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6. Sci Rep. 2019. PMID: 31619708 Free PMC article.
-
Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy.BMC Ophthalmol. 2025 Mar 28;25(1):159. doi: 10.1186/s12886-025-03984-2. BMC Ophthalmol. 2025. PMID: 40155830 Free PMC article.
-
Management of proliferative diabetic retinopathy.Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
-
The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy.Eur J Ophthalmol. 2021 Nov;31(6):3057-3067. doi: 10.1177/1120672120980686. Epub 2020 Dec 18. Eur J Ophthalmol. 2021. PMID: 33334171
Cited by
-
The role of artificial intelligence in analysis of biofluid markers for diagnosis and management of glaucoma: A systematic review.Eur J Ophthalmol. 2023 Sep;33(5):1816-1833. doi: 10.1177/11206721221140948. Epub 2022 Nov 25. Eur J Ophthalmol. 2023. PMID: 36426575 Free PMC article.
References
-
- Sima P, Zoran T. Long-term results of vitreous surgery for proliferative diabetic retinopathy. Doc Ophthalmol. 1994;87:223–232. - PubMed
-
- Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2009;29:464–472. - PubMed
-
- Goto A, Inatani M, Inoue T, et al. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. J Glaucoma. 2013;22:572–576. - PubMed
-
- Huang CH, Hsieh YT, Yang CM. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017;255:863–871. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources